Cribriform DCIS prognosis: what the diagnosis means

Cribriform describes a sieve-like growth pattern seen under the microscope. DCIS means abnormal cells remain inside the milk ducts and have not invaded nearby breast tissue. The pattern is only one part of the report: cell grade, the span of DCIS, hormone-receptor findings and the distance between DCIS and the specimen edge all influence the treatment discussion.

A close or involved surgical margin can mean abnormal cells may remain locally, so further surgery may be considered. Your clinician interprets these details together rather than using the word cribriform alone to predict an individual outcome.

Review the biopsy and imaging results with a breast specialist. Treatment may involve breast-conserving surgery or mastectomy, depending on the extent and location of DCIS, breast size, margin results and your preferences. Radiotherapy may be discussed after breast-conserving surgery, while hormone therapy may be considered when the cells have relevant receptors.

Keep the final pathology report and ask for a clear follow-up plan. Follow-up commonly includes breast examinations and imaging suited to the breast tissue that remains.

After a biopsy or operation, seek prompt medical advice for worsening redness, swelling, heat, drainage, fever, uncontrolled pain or bleeding that does not stop with firm pressure. Call your breast clinic if you notice a new breast or underarm lump, nipple discharge, skin dimpling or a persistent change near the treated area. These changes need assessment but do not by themselves establish that DCIS has returned or become invasive.

Ask what the grade and measured extent are, whether the margins are clear, and whether any invasive cancer was found. Clarify which surgery fits the affected area, whether radiotherapy or hormone therapy could add benefit in your situation, and what imaging schedule is planned afterward.